GleamWall
中文EN

RFL Rafael Holdings, Inc.

Pharmaceutical Preparations · NYSE · SEC CIK 1713863 · Fiscal year ends 07/31

Financial factors as of 2026-07-31 (2026Q4), TTM = sum of the last four quarters

Growth

TTM revenue YoY-4.7%
TTM net income YoY-58.3%
TTM EPS YoY44.2%
Revenue 3-yr CAGR46.3%
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin-3,821.2%
Net margin-3,390.7%
FCF margin—
EBITDA margin-3,797.8%

Returns

ROE-36.9%
ROA-30.1%
ROIC (approx.)-61.5%
Asset turnover0.01x

Leverage & solvency

Liabilities / assets13.3%
Debt / equity0.00x
Current ratio2.35x
Interest coverage-100.29x

Cash quality & payout

Operating cash flow / net income1.01x
Accruals ratio0.4%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q4*2026-07-312026Q32026-04-302026Q22026-01-312026Q12025-10-312025Q4*2025-07-312025Q32025-04-302025Q22025-01-312025Q12024-10-31
Income statement
Revenue$244,000$179,000$211,000$240,000$350,000$362,000$77,000$128,000
Cost of revenue——————$38,000$37,000
Gross profit——————$39,000$91,000
R&D expense$7.47M$4.85M$4.53M$7.48M$232,000$3.00M$947,000$1.33M
SG&A expense$2.44M$2.14M$2.27M$2.84M$58,000$3.17M$2.59M$2.52M
Operating income-$9.73M-$6.87M-$6.66M-$10.14M-$12.76M-$5.91M-$6.64M-$3.84M
Interest expense$6,000$6,000$161,000$160,000$168,000$165,000$163,000$162,000
Pretax income-$9.00M-$2.89M-$6.28M-$9.79M-$12.23M-$6.46M-$5.31M-$9.20M
Income tax-$65,000$6,000$48,000$10,000-$174,000-$2.41M$20,000$12,000
Net income-$9.18M-$4.23M-$6.42M-$9.82M-$290,000-$4.78M-$4.64M-$9.01M
EBITDA-$9.68M-$6.82M-$6.60M-$10.09M-$12.71M-$5.85M-$6.55M-$3.76M
EPS (basic)—-0.08-0.13-0.19—-0.19-0.19-0.37
EPS (diluted)—-0.08-0.13-0.19—-0.19-0.19-0.37
Weighted avg. shares (diluted)—51.23M51.23M51.18M—25.24M24.15M24.06M
Balance sheet
Cash & equivalents$22.10M$30.50M$37.78M$45.54M$52.77M$52.77M$48.32M$8.16M
Short-term investments———————$46.14M
Receivables$444,000$294,000$295,000$413,000$627,000$414,000$200,000$201,000
Inventory$377,000$276,000$271,000$272,000$281,000$288,000——
Current assets$25.82M$34.86M$42.45M$48.32M$56.71M$42.44M$65.83M$70.48M
PP&E, net$1.50M$1.52M$1.54M$1.56M$1.60M$1.61M$1.93M$2.08M
Goodwill$19.94M$19.94M$19.94M$19.94M$19.94M$28.28M—$3.05M
Intangibles$863,000$896,000$929,000$962,000$994,000$1.03M$1.79M$1.82M
Total assets$83.06M$91.99M$99.31M$105.38M$114.11M$108.10M$83.04M$87.83M
Current liabilities$10.99M$11.02M$12.36M$12.08M$11.60M$11.03M$7.11M$7.24M
Total liabilities$11.09M$11.19M$16.06M$16.20M$15.74M$23.58M$10.48M$10.45M
Shareholders' equity$66.31M$75.39M$79.17M$85.18M$94.39M$80.58M$69.38M$73.52M
Cash flow statement
Operating cash flow-$8.37M-$7.28M-$7.52M-$6.81M-$10.38M-$3.19M-$2.31M-$3.04M
Capital expenditure-$2,000$0——-$1,000-$1,000$0$6,000
Free cash flow-$8.37M-$7.28M——-$10.38M-$3.19M-$2.31M-$3.05M
Investing cash flow$3,000$6,000-$255,000-$430,000$163,000-$7.20M$42.50M$8.57M
Financing cash flow-$26,000-$28,000-$32,000-$30,000$24.89M$11,000-$27,000-$48,000
Depreciation & amortization$51,000$48,000$55,000$50,000$50,000$62,000$90,000$86,000
Stock-based compensation$231,000$172,000$387,000$598,000$909,000$353,000$502,000$359,000

Free plan shows the latest 8 periods; Pro shows all 39 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.